IBDEI1CM ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21796,0)
 ;;=L40.9^^70^929^17
 ;;^UTILITY(U,$J,358.3,21796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21796,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,21796,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,21796,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,21797,0)
 ;;=L40.3^^70^929^19
 ;;^UTILITY(U,$J,358.3,21797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21797,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,21797,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,21797,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,21798,0)
 ;;=R21.^^70^929^20
 ;;^UTILITY(U,$J,358.3,21798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21798,1,3,0)
 ;;=3^Rash/Oth Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,21798,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,21798,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,21799,0)
 ;;=L25.9^^70^929^6
 ;;^UTILITY(U,$J,358.3,21799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21799,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,21799,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,21799,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,21800,0)
 ;;=M34.89^^70^930^31
 ;;^UTILITY(U,$J,358.3,21800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21800,1,3,0)
 ;;=3^Systemic Sclerosis NEC
 ;;^UTILITY(U,$J,358.3,21800,1,4,0)
 ;;=4^M34.89
 ;;^UTILITY(U,$J,358.3,21800,2)
 ;;=^5011784
 ;;^UTILITY(U,$J,358.3,21801,0)
 ;;=M34.0^^70^930^25
 ;;^UTILITY(U,$J,358.3,21801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21801,1,3,0)
 ;;=3^Progressive Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,21801,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,21801,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,21802,0)
 ;;=F03.90^^70^930^15
 ;;^UTILITY(U,$J,358.3,21802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21802,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,21802,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,21802,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,21803,0)
 ;;=F06.8^^70^930^22
 ;;^UTILITY(U,$J,358.3,21803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21803,1,3,0)
 ;;=3^Mental Disorders d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,21803,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,21803,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,21804,0)
 ;;=F06.1^^70^930^1
 ;;^UTILITY(U,$J,358.3,21804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21804,1,3,0)
 ;;=3^Catatonic Disorder d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,21804,1,4,0)
 ;;=4^F06.1
 ;;^UTILITY(U,$J,358.3,21804,2)
 ;;=^5003054
 ;;^UTILITY(U,$J,358.3,21805,0)
 ;;=G35.^^70^930^23
 ;;^UTILITY(U,$J,358.3,21805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21805,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,21805,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,21805,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,21806,0)
 ;;=G60.9^^70^930^20
 ;;^UTILITY(U,$J,358.3,21806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21806,1,3,0)
 ;;=3^Hereditary/Idiopathic Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,21806,1,4,0)
 ;;=4^G60.9
 ;;^UTILITY(U,$J,358.3,21806,2)
 ;;=^5004071
 ;;^UTILITY(U,$J,358.3,21807,0)
 ;;=G62.9^^70^930^24
 ;;^UTILITY(U,$J,358.3,21807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21807,1,3,0)
 ;;=3^Polyneuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,21807,1,4,0)
 ;;=4^G62.9
 ;;^UTILITY(U,$J,358.3,21807,2)
 ;;=^5004079
 ;;^UTILITY(U,$J,358.3,21808,0)
 ;;=I63.9^^70^930^14
 ;;^UTILITY(U,$J,358.3,21808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21808,1,3,0)
 ;;=3^Cerebral Infarction,Unspec
